[Disease burden and future trend predictions of age-related hearing loss in China and worldwide from 1990 to 2021].

Q3 Medicine
北京大学学报(医学版) Pub Date : 2025-06-18
A Anargul, Y Song, X Yan, Y Gao, B Liu, G Hu
{"title":"[Disease burden and future trend predictions of age-related hearing loss in China and worldwide from 1990 to 2021].","authors":"A Anargul, Y Song, X Yan, Y Gao, B Liu, G Hu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe the trend of changes in the disease burden of age-related hearing loss in China and globally from 1990 to 2021, to forecast the prevalence and years lived with disability (YLD) rates of age-related hearing loss from 2022 to 2036, and to provide a reference for the prevention and control of the disease burden associated with age-related hearing loss.</p><p><strong>Methods: </strong>Using the Global Burden of Disease 2021 (GBD2021) data, this study selected age-standardized prevalence rate (ASPR) and YLD as indicators. The disease burden and long-term trends of age-related hearing loss in China and globally from 1990 to 2021 were described by different socio-demographic index (SDI) and gender. Joinpoint regression was used to calculate the average annual percent change (AAPC) to assess the trend changes in the disease burden. Decomposition analysis was applied to explore the relative impacts of aging, population growth, and epidemiological changes on the variation in disease burden. An autoregressive integrated moving average (ARIMA) model was used to forecast the age-standardized pre-valence rate and YLD rates from 2022 to 2036.</p><p><strong>Results: </strong>The prevalence of age-related hearing loss in China in 2021 was 82 162.49 (73 288.08-89 187.21) per 100 000, higher than the global SDI level of 66 238.16 (59 982.54-72 669.82) per 100 000, the high SDI region ' s level of 57 650.42 (52 059.12-63 889.02) per 100 000, the upper-middle SDI region ' s level of 69 115.59 (62 494.18- 75 340.64) per 100 000, the middle SDI region ' s level of 72 365.56 (65 181.43-78 912.01) per 100 000, the lower-middle SDI region ' s level of 64 439.66 (58 368.22-71 468.27) per 100 000, and the low SDI region ' s level of 61 725.25 (55 749.18-68 477.67) per 100 000. The age- related hearing loss YLD rate in China was 2 762.98 [95% uncertainty interval (<i>UI</i>): 1 855.28-3 880.68] per 100 000, higher than the global SDI level of 2 236.75 (95%<i>UI</i>: 1 511.56-3 155.88) per 100 000, the high SDI region ' s level of 1 805.79 (95%<i>UI</i>: 1 212.69-2 577.17) per 100 000, the upper-middle SDI region ' s level of 2 316.58 (95%<i>UI</i>: 1 557.53-3 274.87) per 100 000, the middle SDI region ' s level of 2 480.99 (95%<i>UI</i>: 1 678.17-3 489.24) per 100 000, the lower-middle SDI region ' s level of 2 313.28 (95%<i>UI</i>: 1 578.35-3 271.50) per 100 000, and the low SDI region ' s level of 2 383.55 (95%<i>UI</i>: 1 623.66-3 365.68) per 100 000. From 1990 to 2021, both the prevalence and YLD rate of age-related hearing loss in China showed an increasing trend, rising by an average of 0.18% (95%<i>CI</i>: 0.16%-0.19%) and 0.29% (95%<i>CI</i>: 0.27%-0.30%) per year, respectively. The rates of increase in prevalence were the same for both men and women, with men showing a 0.18% increase (95%<i>CI</i>: 0.17%-0.19%, <i>P</i> < 0.001) and women showing a 0.18% increase (95%<i>CI</i>: 0.16%-0.19%, <i>P</i> < 0.001). However, the YLD rate increase was faster in men than in women, with men experiencing a 0.32% increase (95%<i>CI</i>: 0.27%-0.37%, <i>P</i> < 0.001) and women experiencing a 0.27% increase (95%<i>CI</i>: 0.26%-0.28%, <i>P</i> < 0.001). Decomposition analysis showed that population growth was the main factor driving the increase in prevalence and YLD rate globally and across different SDI regions. However, aging was the primary factor contributing to the increase in prevalence and YLD rate in China. ARIMA model predictions suggested that the prevalence and YLD rate of age-related hearing loss would continue to rise from 2022 to 2036, with the predicted prevalence and YLD rate in 2036 reaching 89 723.99 per 100 000 and 2 872.47 per 100 000, respectively.</p><p><strong>Conclusion: </strong>The prevalence and disease burden of age-related hearing loss in individuals aged 60 and above in China rank first globally. From 1990 to 2021, both the prevalence and YLD rate of age-related hearing loss have shown a continuous upward trend, consistently surpassing the levels observed in various SDI regions worldwide. The prevalence and disease burden of age-related hearing loss are particularly significant among elderly men. Moreover, projections indicate that the disease burden of age-related hearing loss will continue to rise over the next 15 years. Therefore, it is urgent to pay close attention to age-related hearing loss in this specific population, and early intervention measures are crucial to reduce the disease burden associated with age-related hearing loss.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"545-553"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171594/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"北京大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To describe the trend of changes in the disease burden of age-related hearing loss in China and globally from 1990 to 2021, to forecast the prevalence and years lived with disability (YLD) rates of age-related hearing loss from 2022 to 2036, and to provide a reference for the prevention and control of the disease burden associated with age-related hearing loss.

Methods: Using the Global Burden of Disease 2021 (GBD2021) data, this study selected age-standardized prevalence rate (ASPR) and YLD as indicators. The disease burden and long-term trends of age-related hearing loss in China and globally from 1990 to 2021 were described by different socio-demographic index (SDI) and gender. Joinpoint regression was used to calculate the average annual percent change (AAPC) to assess the trend changes in the disease burden. Decomposition analysis was applied to explore the relative impacts of aging, population growth, and epidemiological changes on the variation in disease burden. An autoregressive integrated moving average (ARIMA) model was used to forecast the age-standardized pre-valence rate and YLD rates from 2022 to 2036.

Results: The prevalence of age-related hearing loss in China in 2021 was 82 162.49 (73 288.08-89 187.21) per 100 000, higher than the global SDI level of 66 238.16 (59 982.54-72 669.82) per 100 000, the high SDI region ' s level of 57 650.42 (52 059.12-63 889.02) per 100 000, the upper-middle SDI region ' s level of 69 115.59 (62 494.18- 75 340.64) per 100 000, the middle SDI region ' s level of 72 365.56 (65 181.43-78 912.01) per 100 000, the lower-middle SDI region ' s level of 64 439.66 (58 368.22-71 468.27) per 100 000, and the low SDI region ' s level of 61 725.25 (55 749.18-68 477.67) per 100 000. The age- related hearing loss YLD rate in China was 2 762.98 [95% uncertainty interval (UI): 1 855.28-3 880.68] per 100 000, higher than the global SDI level of 2 236.75 (95%UI: 1 511.56-3 155.88) per 100 000, the high SDI region ' s level of 1 805.79 (95%UI: 1 212.69-2 577.17) per 100 000, the upper-middle SDI region ' s level of 2 316.58 (95%UI: 1 557.53-3 274.87) per 100 000, the middle SDI region ' s level of 2 480.99 (95%UI: 1 678.17-3 489.24) per 100 000, the lower-middle SDI region ' s level of 2 313.28 (95%UI: 1 578.35-3 271.50) per 100 000, and the low SDI region ' s level of 2 383.55 (95%UI: 1 623.66-3 365.68) per 100 000. From 1990 to 2021, both the prevalence and YLD rate of age-related hearing loss in China showed an increasing trend, rising by an average of 0.18% (95%CI: 0.16%-0.19%) and 0.29% (95%CI: 0.27%-0.30%) per year, respectively. The rates of increase in prevalence were the same for both men and women, with men showing a 0.18% increase (95%CI: 0.17%-0.19%, P < 0.001) and women showing a 0.18% increase (95%CI: 0.16%-0.19%, P < 0.001). However, the YLD rate increase was faster in men than in women, with men experiencing a 0.32% increase (95%CI: 0.27%-0.37%, P < 0.001) and women experiencing a 0.27% increase (95%CI: 0.26%-0.28%, P < 0.001). Decomposition analysis showed that population growth was the main factor driving the increase in prevalence and YLD rate globally and across different SDI regions. However, aging was the primary factor contributing to the increase in prevalence and YLD rate in China. ARIMA model predictions suggested that the prevalence and YLD rate of age-related hearing loss would continue to rise from 2022 to 2036, with the predicted prevalence and YLD rate in 2036 reaching 89 723.99 per 100 000 and 2 872.47 per 100 000, respectively.

Conclusion: The prevalence and disease burden of age-related hearing loss in individuals aged 60 and above in China rank first globally. From 1990 to 2021, both the prevalence and YLD rate of age-related hearing loss have shown a continuous upward trend, consistently surpassing the levels observed in various SDI regions worldwide. The prevalence and disease burden of age-related hearing loss are particularly significant among elderly men. Moreover, projections indicate that the disease burden of age-related hearing loss will continue to rise over the next 15 years. Therefore, it is urgent to pay close attention to age-related hearing loss in this specific population, and early intervention measures are crucial to reduce the disease burden associated with age-related hearing loss.

[1990 - 2021年中国及全球年龄相关性听力损失的疾病负担及未来趋势预测]。
目的:描述1990 - 2021年中国及全球年龄相关性听力损失疾病负担变化趋势,预测2022 - 2036年年龄相关性听力损失患病率和残疾年(YLD)率,为预防和控制年龄相关性听力损失疾病负担提供参考。方法:采用全球疾病负担2021 (GBD2021)数据,选择年龄标准化患病率(ASPR)和YLD作为指标。用不同的社会人口指数(SDI)和性别描述了1990年至2021年中国和全球年龄相关性听力损失的疾病负担和长期趋势。采用关节点回归计算平均年变化百分比(AAPC),评估疾病负担的趋势变化。采用分解分析探讨老龄化、人口增长和流行病学变化对疾病负担变化的相对影响。采用自回归综合移动平均(ARIMA)模型预测2022 - 2036年年龄标准化前价率和YLD率。结果:2021年在中国的患病率与年龄相关的听力损失是82 162.49(每100 000 73 288.08 -89 187.21),高于66年的全球SDI级别每100 000 238.16 982.54 -72 669.82(59),高SDI地区的年代57 650.42每100 000(52 059.12 -63 889.02),中上SDI地区的水平69 115.59(每100 000 62 494.18 - 75 340.64),中间SDI地区的水平72 365.56(每100 000 65 181.43 -78 912.01),中下SDI区为64 439.66(58 368.22 ~ 71 468.27)/ 10万,低SDI区为61 725.25(55 749.18 ~ 68 477.67)/ 10万。年龄相关听力损失在中国收获率率2 762.98(95%不确定性区间(UI): 1 880.68 855.28 - 3]每100人000人,高于全球SDI 2水平236.75 155.88 (95% UI: 1 511.56 - 3) 100 000,高SDI地区的s水平1 805.79 577.17 (95% UI: 1 - 212.69 2) 100 000,中上SDI地区的s水平2 316.58 274.87 (95% UI: 1 557.53 - 3) 100 000,中间SDI地区的水平2 480.99(95%用户界面:1 678.17 ~ 3 489.24) / 10万,中下地区为2 313.28 (95%UI: 1 578.35 ~ 3 271.50) / 10万,低地区为2 383.55 (95%UI: 1 623.66 ~ 3 365.68) / 10万。1990 - 2021年,中国年龄相关性听力损失患病率和YLD率均呈上升趋势,年均上升0.18% (95%CI: 0.16%-0.19%),年均上升0.29% (95%CI: 0.27%-0.30%)。男性和女性的患病率增加率相同,男性增加0.18% (95%CI: 0.17%-0.19%, P < 0.001),女性增加0.18% (95%CI: 0.16%-0.19%, P < 0.001)。然而,男性的YLD增加速度比女性快,男性增加0.32% (95%CI: 0.27%-0.37%, P < 0.001),女性增加0.27% (95%CI: 0.26%-0.28%, P < 0.001)。分解分析表明,人口增长是推动全球和不同SDI区域患病率和YLD率上升的主要因素。然而,在中国,老龄化是导致患病率和YLD率上升的主要因素。ARIMA模型预测,2022 - 2036年,年龄相关性听力损失患病率和YLD率将持续上升,2036年预测患病率和YLD率分别达到89 723.99 / 10万和2 872.47 / 10万。结论:中国60岁及以上人群年龄相关性听力损失患病率和疾病负担居全球首位。从1990年到2021年,年龄相关性听力损失的患病率和YLD率均呈现持续上升趋势,持续超过全球各SDI地区的水平。年龄相关性听力损失的患病率和疾病负担在老年男性中尤为显著。此外,预测表明,与年龄有关的听力损失的疾病负担将在未来15年内继续上升。因此,迫切需要密切关注这一特定人群的年龄相关性听力损失,早期干预措施对于减少年龄相关性听力损失相关的疾病负担至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
北京大学学报(医学版)
北京大学学报(医学版) Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
9815
期刊介绍: Beijing Da Xue Xue Bao Yi Xue Ban / Journal of Peking University (Health Sciences), established in 1959, is a national academic journal sponsored by Peking University, and its former name is Journal of Beijing Medical University. The coverage of the Journal includes basic medical sciences, clinical medicine, oral medicine, surgery, public health and epidemiology, pharmacology and pharmacy. Over the last few years, the Journal has published articles and reports covering major topics in the different special issues (e.g. research on disease genome, theory of drug withdrawal, mechanism and prevention of cardiovascular and cerebrovascular diseases, stomatology, orthopaedic, public health, urology and reproductive medicine). All the topics involve latest advances in medical sciences, hot topics in specific specialties, and prevention and treatment of major diseases. The Journal has been indexed and abstracted by PubMed Central (PMC), MEDLINE/PubMed, EBSCO, Embase, Scopus, Chemical Abstracts (CA), Western Pacific Region Index Medicus (WPR), JSTChina, and almost all the Chinese sciences and technical index systems, including Chinese Science and Technology Paper Citation Database (CSTPCD), Chinese Science Citation Database (CSCD), China BioMedical Bibliographic Database (CBM), CMCI, Chinese Biological Abstracts, China National Academic Magazine Data-Base (CNKI), Wanfang Data (ChinaInfo), etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信